Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
Dow
Baxter
Moodys

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021187

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 021187 describes NUVARING, which is a drug marketed by Organon Sub Merck and is included in one NDA. It is available from three suppliers. Additional details are available on the NUVARING profile page.

The generic ingredient in NUVARING is ethinyl estradiol; etonogestrel. There are twenty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; etonogestrel profile page.
Summary for 021187
Tradename:NUVARING
Applicant:Organon Sub Merck
Ingredient:ethinyl estradiol; etonogestrel
Patents:0
Pharmacology for NDA: 021187
Mechanism of ActionEstrogen Receptor Agonists
Suppliers and Packaging for NDA: 021187
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NUVARING ethinyl estradiol; etonogestrel RING;VAGINAL 021187 NDA Organon USA Inc. 0052-0273 0052-0273-03 3 POUCH in 1 BOX (0052-0273-03) > 21 d in 1 POUCH (0052-0273-01)
NUVARING ethinyl estradiol; etonogestrel RING;VAGINAL 021187 NDA Organon USA Inc. 0052-0273 0052-0273-05 3 POUCH in 1 BOX (0052-0273-05) > 21 d in 1 POUCH (0052-0273-04)
Paragraph IV (Patent) Challenges for 021187
Tradename Dosage Ingredient NDA Submissiondate
NUVARING RING;VAGINAL ethinyl estradiol; etonogestrel 021187 2013-06-17

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:RING;VAGINALStrength0.015MG/24HR;0.12MG/24HR
Approval Date:Oct 3, 2001TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
McKinsey
Baxter
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.